Medicare Enrolled

Dr. Henrik Illum, M.D.

Hematology & Oncology · Bedford, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1615 HOSPITAL PARKWAY, Bedford, TX 76022
8173545581
In practice since 2007 (18 years)
NPI: 1982805164 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Illum from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Illum? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Illum

Dr. Henrik Illum is a hematology & oncology in Bedford, TX, with 18 years in practice. Based on federal Medicare data, Dr. Illum performed 95,992 Medicare services across 2,926 unique beneficiaries.

Between the years covered by Open Payments, Dr. Illum received a total of $1,468 from 26 pharmaceutical and/or device companies across 52 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Illum is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 9% volume in TX$ $1,468 industry payments

Medicare Practice Summary

Medicare Utilization ↗
95,992
Medicare services
Top 9% in TX for hematology & oncology
2,926
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,333 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron sucrose injection (Venofer)25,200$0$2
Iron infusion (Feraheme)19,890$0$5
Darbepoetin injection (Aranesp) for anemia19,600$2$20
Pembrolizumab injection (Keytruda)10,700$43$137
Contrast dye for imaging (iodine-based)7,164$0$3
Paclitaxel chemotherapy injection2,892$0$8
Dexamethasone injection (steroid)1,364$0$1
Denosumab injection (Prolia/Xgeva)1,260$19$66
Complete blood count (CBC) with differential1,045$8$36
Comprehensive metabolic blood panel959$10$64
Injection, granisetron hydrochloride, 100 mcg870$0$24
Office visit, established patient (30-39 min)821$89$368
Blood draw (venipuncture)717$8$20
Iron level test253$6$27
Iron binding capacity test253$9$35
Ferritin level test (iron stores)250$13$60
Anti-nausea injection (Aloxi/palonosetron)240$1$114
Administration of chemotherapy into vein, 1 hour or less237$100$707
Hospital follow-up visit, moderate complexity225$60$247
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less222$48$313
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less201$22$157
Drug injection, under skin or into muscle182$11$96
Injection, zoledronic acid, 1 mg126$7$431
Reticulated (young) platelet measurement92$34$143
Lactate dehydrogenase (enzyme) level90$6$31
Microscopic examination for white blood cells with manual cell count89$4$22
Complete blood count (CBC), automated89$6$34
Infusion, normal saline solution , 1000 cc87$2$19
Ct scan of chest with contrast71$55$821
Infusion into a vein for hydration, 31-60 minutes67$23$256
New patient office visit (45-59 min)59$122$565
CT scan of abdomen and pelvis with contrast56$167$1,067
Carcinoembryonic antigen (cea) protein level56$18$99
Hospital follow-up visit, high complexity55$92$357
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle52$26$145
Injection, diphenhydramine hcl, up to 50 mg51$1$7
Drawing of blood for a medical problem48$62$264
Office visit, established patient, complex (40-54 min)44$135$496
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour40$15$100
Administration of additional new drug or substance into vein, 1 hour or less38$51$344
Administration of chemotherapy into vein, each additional hour35$21$161
Irrigation of implanted venous access drug delivery device34$19$114
CT scan of chest, without contrast29$50$686
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries28$87$657
Nuclear medicine study from skull base to mid-thigh with ct scan26$1,143$4,802
Unclassified drugs26$1$8
Initial hospital admission, moderate complexity21$101$470
Red blood cell sedimentation rate, to detect inflammation, non-automated19$4$33
Injection of additional new drug or substance into vein19$12$108
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
21.4% high complexity
73.1% medium
5.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,468
Total received (2018-2024)
Avg $245/year across 6 years
Bottom 35% in TX for hematology & oncology
26
Companies
52
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$914 (62.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$554 (37.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$467
2023
$309
2022
$389
2021
$12
2019
$218
2018
$74

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$255
Novocure GmbH
$250
Seattle Genetics, Inc.
$118
Incyte Corporation
$100
Janssen Biotech, Inc.
$99
E.R. Squibb & Sons, L.L.C.
$88
Daiichi Sankyo Inc.
$57
AstraZeneca Pharmaceuticals LP
$48
Novartis Pharmaceuticals Corporation
$45
GlaxoSmithKline, LLC.
$33
EMD Serono, Inc.
$31
GENZYME CORPORATION
$31
EISAI INC.
$31
Kite Pharma, Inc.
$30
Medtronic, Inc.
$29
Tempus AI, Inc
$27
Foundation Medicine, Inc.
$26
SOBI, INC
$24
Sirtex Medical Inc
$23
ARRAY BIOPHARMA INC
$23
PFIZER INC.
$21
Eisai Inc.
$21
Karyopharm Therapeutics Inc.
$16
Agios Pharmaceuticals, Inc.
$15
Astellas Pharma US Inc
$14
Gilead Sciences, Inc.
$12
Top 3 companies account for 42.5% of total payments
Associated products mentioned in payments ›
ADCETRIS · CABLIVI · ERLEADA · Enhertu · IMBRUVICA · IMFINZI · KISQALI · Lenvima · MEKINIST · OJJAARA · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION SYSTEM · PYRUKYND · Padcev · Pomalyst · REBLOZYL · SIR-Spheres Microspheres · VONJO · XALKORI · XPOVIO · XT CDX · XTANDI · Yescarta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (62%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2 per 100 Medicare services performed
Looking for a hematology & oncology in Bedford?
Compare hematology & oncologys in the Bedford area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
144
Per 100K population
6.7
County median income
$81,905
Nearest hospital
TEXAS HEALTH HARRIS METHODIST HURST-EULESS-BEDFORD
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Illum is a mixed practice specialist, with above-average Medicare volume (top 9% in TX), and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Illum experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Illum performed 25,200 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Illum receive payments from pharmaceutical companies?
Yes. Dr. Illum received a total of $1,468 from 26 companies across 52 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Illum's costs compare to other hematology & oncologys in Bedford?
Dr. Illum's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Illum) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →